Physician profile
Gary L Weinstein
NPI 1275617920
$102,664.04
in general payments reported to CMS, 2019-2025
38 companies · $2,196 in 2025
The $2,196 reported for 2025 was more than what 88% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,378 · 2020: $13K · 2021: $11K · 2022: $375 · 2023: $34K · 2024: $36K · 2025: $2,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $66K · Food and Beverage: $4,516 · Travel and Lodging: $2,171 · Education: $53.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $65,650.00 |
| Food and Beverage | $4,515.52 |
| Travel and Lodging | $2,170.89 |
| Education | $53.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $98,622.12 | 2019-2025 | Arexvy, Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $848.05 | 2020-2025 | Ofev, Jascayd |
| Astrazeneca Pharmaceuticals LP | $644.68 | 2022-2025 | Fasenra, Tezspire, Airsupra |
| Inari Medical, INC. | $351.37 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Aop Health US, LLC | $214.69 | 2025 | Rapiblyk |
| Insmed, INC. | $206.39 | 2024-2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $165.16 | 2024-2025 | Prolastin-C Liquid |
| Inspire Medical Systems, INC. | $145.29 | 2024 | Inspire |
| Baxter Healthcare | $142.95 | 2021-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Genzyme Corporation | $138.65 | 2023-2025 | |
| Amgen INC. | $99.02 | 2022-2025 | Tezspire, Tavneos |
| Merck Sharp & Dohme LLC | $75.26 | 2022-2024 | Zerbaxa, Recarbrio |
| Lilly USA, LLC | $69.88 | 2025 | Zepbound, Kisunla |
| Tactile Systems Technology INC | $69.50 | 2021 | |
| Paratek Pharmaceuticals, INC. | $68.10 | 2021-2024 | Nuzyra |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $66.81 | 2021-2025 | Smartvest |
| Philips North America LLC | $62.62 | 2019-2024 | (Ak6) Vest Therapy |
| Takeda Pharmaceuticals U.S.A., INC. | $59.63 | 2024-2025 | Glassia |
| Abbvie INC. | $55.06 | 2023-2024 | Avycaz |
| Resmed Corp | $53.96 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $47.76 | 2024 | Uptravi, Opsumit |
| Ani Pharmaceuticals, INC. | $43.08 | 2024 | Purified Cortrophin Gel |
| Viatris Specialty LLC | $42.99 | 2025 | Yupelri |
| Verona Pharma, INC. | $39.02 | 2025 | Ohtuvayre |
| Hospira, INC. | $38.07 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $36.83 | 2024 | Dupixent |
| Caris Mpi, INC. | $33.24 | 2025 | Mi Cancer Seek |
| United Therapeutics Corporation | $32.21 | 2025 | Tyvaso |
| Pfizer INC. | $31.77 | 2025 | |
| Vapotherm INC | $28.16 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $25.84 | 2022 | |
| Itamar Medical INC | $22.12 | 2022 | |
| Hikma Pharmaceuticals USA | $21.20 | 2025 | Ryaltris |
| Ethicon INC. | $17.47 | 2025 | Monarch Platform |
| Inogen, INC. | $16.28 | 2025 | |
| Csl Behring | $14.64 | 2020 | |
| Mallinckrodt Hospital Products INC. | $14.17 | 2024 | Acthar |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.